| Literature DB >> 29663668 |
Lea Bircher1, Annelies Geirnaert1, Frederik Hammes2, Christophe Lacroix1, Clarissa Schwab1.
Abstract
Strict anaerobic gut microbes have been suggested as 'next-generation probiotics' for treating several intestinal disorders. The development of preservation techniques is of major importance for therapeutic application. This study investigated cryopreservation (-80°C) and lyophilization survival and storage stability (4°C for 3 months) of the strict anaerobic gut microbes Bacteroides thetaiotaomicron, Faecalibacterium prausnitzii, Roseburia intestinalis, Anaerostipes caccae, Eubacterium hallii and Blautia obeum. To improve preservation survival, protectants sucrose and inulin (both 5% w/v) were added for lyophilization and were also combined with glycerol (15% v/v) for cryopreservation. Bacterial fitness, evaluated by maximum growth rate and lag phase, viability and membrane integrity were determined using a standardized growth assay and by flow cytometry as markers for preservation resistance. Lyophilization was more detrimental to viability and fitness than cryopreservation, but led to better storage stability. Adding sucrose and inulin enhanced viability and the proportion of intact cells during lyophilization of all strains. Viability of protectant-free B. thetaiotaomicron, A. caccae and F. prausnitzii was above 50% after cryopreservation and storage and increased to above 80% if protectants were present. The addition of glycerol, sucrose and inulin strongly enhanced the viability of B. obeum, E. hallii and R. intestinalis from 0.03-2% in protectant-free cultures to 11-37%. This is the first study that quantitatively compared the effect of cryopreservation and lyophilization and the addition of selected protectants on viability and fitness of six strict anaerobic gut microbes. Our results suggest that efficiency of protectants is process- and species-specific.Entities:
Mesh:
Year: 2018 PMID: 29663668 PMCID: PMC6011992 DOI: 10.1111/1751-7915.13265
Source DB: PubMed Journal: Microb Biotechnol ISSN: 1751-7915 Impact factor: 5.813
Figure 1Set‐up of preservation experiments. Early stationary phase cultures were incubated for 30 min in buffers containing sucrose and inulin (SI), sucrose, inulin and glycerol (GSI) and in control buffer lacking protectants (control) before processing for preservation. Viability and growth were assessed at three different time points indicated by red dots. The first assessment was performed with fresh cultures after incubation in the protective and control buffers (t 0). The second assessment was conducted with the processed cultures immediately after freezing, respectively, lyophilization (t 1) and the third assessment with cryopreserved and lyophilized samples stored for 3 months at −80°C or 4°C, respectively (t 2).
Impact of protectants and cryopreservation on cell viability of fresh (t 0), processed (t 1) and stored (t 2) bacteria. Log viable cell counts ml−1 in the fresh culture, after freezing in liquid nitrogen and cryopreservation for 3 months at −80°C, were assessed with the most probable number method (MPN). Recovery rate of viable cells (in %) was calculated relative to the average viable cell counts in the fresh control (vs. control t 0) and fresh treatment culture (vs. t 0)
| Organism | Culture condition | Control | SI | GSI | |||
|---|---|---|---|---|---|---|---|
| MPN (ml−1) | Recovery vs. t0 | MPN (ml−1) | Recover vs. control | MPN (ml−1) | Recovery vs. control | ||
|
| Fresh ( | 9.3 ± 0.2 | 9.4 ± 0.2 | 135 | 8.9 ± 0.3 | 45 | |
| Processed ( | 9.2 ± 0.3 | 85 | 9.3 ± 0.2 | 114/84 | 8.8 ± 0.6 | 31/70 | |
| Stored ( | 9.2 ± 0.2 | 93 | 9.3 ± 0.2 | 100/91 | 9.0 ± 0.2 | 60/134 | |
|
| Fresh ( | 7.9 ± 0.4 | 7.8 ± 0.4 | 79 | 8.1 ± 0.2 | 139 | |
| Processed ( | 5.7 ± 0.7 | 1 | 7.1 ± 0.5 | 15/19 | 7.7 ± 0.4 | 57/41 | |
| Stored ( | 4.5 ± 0.6 | 0.03 | 6.1 ± 0.4 | 2/2 | 7.0 ± 0.4 | 11/8 | |
|
| Fresh ( | 9.0 ± 0.3 | 8.9 ± 0.4 | 82 | 7.9 ± 0.2 | 9 | |
| Processed ( | 8.4 ± 0.4 | 27 | 8.4 ± 0.3 | 27/33 | 8.3 ± 0.3 | 23/267 | |
| Stored ( | 7.1 ± 0.2 | 1 | 7.7 ± 0.3 | 6/7 | 8.3 ± 0.2 | 21/247 | |
|
| Fresh ( | 8.4 ± 0.2 | 8.4 ± 0.2 | 100 | 8.3 ± 0.2 | 81 | |
| Processed ( | 7.6 ± 0.1 | 16 | 7.8 ± 0.2 | 25/25 | 8.1 ± 0.3 | 52/64 | |
| Stored ( | 6.8 ± 0.6 | 2 | 7.1 ± 0.4 | 6/6 | 7.9 ± 0.4 | 37/45 | |
|
| Fresh ( | 8.8 ± 0.3 | 8.9 ± 0.2 | 122 | 8.6 ± 0.4 | 63 | |
| Processed ( | 8.4 ± 0.2 | 39 | 8.9 ± 0.2 | 104/85 | 8.7 ± 0.2 | 69/109 | |
| Stored ( | 8.5 ± 0.2 | 49 | 8.8 ± 0.3 | 96/78 | 8.8 ± 0.3 | 95/152 | |
|
| Fresh ( | 8.0 ± 0.2 | 8.3 ± 0.3 | 181 | 7.4 ± 0.3 | 27 | |
| Processed ( | 7.9 ± 0.4 | 76 | 7.8 ± 0.3 | 64/36 | 7.1 ± 0.3 | 12/46 | |
| Stored ( | 7.9 ± 0.2 | 80 | 7.6 ± 0.3 | 45/25 | 7.2 ± 0.2 | 16/60 | |
Viable cell counts in samples with cryoprotectants are significantly different from the control samples within the same condition (P ˂ 0.05).
Viable cell counts after processing and after storage are significantly different from the viable cell counts of the fresh culture within the same treatment (P ˂ 0.05).
Impact of protectants and cryopreservation on fitness of fresh (t 0), processed (t 1) and stored (t 2) bacteria. Lag phase (t lag) and maximum growth rate (µmax) of gut microbes after freezing in liquid nitrogen and cryopreservation for 3 months at −80°C were calculated from optical density growth curves based on Baranyi's equation
| Organism | Culture condition | Control | SI | GSI | |||
|---|---|---|---|---|---|---|---|
|
| µmax (OD*h−1) |
| µmax (OD*h−1) |
| µmax (OD*h−1) | ||
|
| Fresh ( | 0.7 ± 0.1 | 0.23 ± 0.01 | 0.7 ± 0.1 | 0.22 ± 0.01 | 1.3 ± 0.6 | 0.22 ± 0.01 |
| Processed ( | 1.1 ± 0.1 | 0.22 ± 0.01 | 0.8 ± 0.1 | 0.20 ± 0.01 | 1.6 ± 0.2 | 0.20 ± 0.01 | |
| Stored ( | 0.8 ± 0.3 | 0.18 ± 0.04 | 0.5 ± 0.3 | 0.16 ± 0.04 | 1.2 ± 0.7 | 0.17 ± 0.04 | |
|
| Fresh ( | 6.4 ± 2.2 | 0.14 ± 0.02 | 7.0 ± 2.1 | 0.14 ± 0.02 | 7.3 ± 1.1 | 0.13 ± 0.03 |
| Processed ( | 15.1 ± 1.0 | 0.23 ± 0.01 | 13.7 ± 2.5 | 0.17 ± 0.05 | 13.0 ± 2.5 | 0.11 ± 0.02 | |
| Stored ( | 19.7 ± 0.8 | 0.26 ± 0.03 | 13.5 ± 0.7 | 0.21 ± 0.03 | 16.1 ± 2.1 | 0.21 ± 0.03 | |
|
| Fresh ( | 1.6 ± 0.1 | 0.29 ± 0.02 | 1.6 ± 0.1 | 0.28 ± 0.01 | 3.3 ± 0.1 | 0.26 ± 0.01 |
| Processed ( | 3.2 ± 0.3 | 0.25 ± 0.01 | 3.1 ± 0.1 | 0.25 ± 0.01 | 3.1 ± 0.1 | 0.27 ± 0.00 | |
| Stored ( | 9.2 ± 0.4 | 0.22 ± 0.02 | 4.7 ± 0.4 | 0.18 ± 0.02 | 4.4 ± 0.5 | 0.22 ± 0.01 | |
|
| Fresh ( | 1.7 ± 0.8 | 0.36 ± 0.04 | 1.5 ± 0.0 | 0.34 ± 0.02 | 1.3 ± 0.2 | 0.23 ± 0.02 |
| Processed ( | 4.1 ± 0.2 | 0.43 ± 0.09 | 3.4 ± 0.6 | 0.41 ± 0.11 | 1.9 ± 0.6 | 0.21 ± 0.04 | |
| Stored ( | 8.1 ± 2.5 | 0.47 ± 0.03 | 7.3 ± 1.3 | 0.43 ± 0.03 | 5.3 ± 0.8 | 0.30 ± 0.02 | |
|
| Fresh ( | 1.5 ± 0.1 | 0.20 ± 0.03 | 1.3 ± 0.2 | 0.19 ± 0.03 | 2.0 ± 0.3 | 0.21 ± 0.02 |
| Processed ( | 2.4 ± 0.2 | 0.15 ± 0.03 | 1.8 ± 0.5 | 0.17 ± 0.02 | 2.2 ± 0.1 | 0.13 ± 0.02 | |
| Stored ( | 3.3 ± 0.6 | 0.16 ± 0.02 | 2.2 ± 0.2 | 0.16 ± 0.00 | 2.1 ± 0.3 | 0.14 ± 0.01 | |
|
| Fresh ( | 1.3 ± 0.1 | 0.05 ± 0.00 | 1.4 ± 0.1 | 0.05 ± 0.00 | 3.6 ± 0.1 | 0.05 ± 0.00 |
| Processed ( | 2.5 ± 0.2 | 0.05 ± 0.01 | 3.3 ± 0.2 | 0.06 ± 0.00 | 4.5 ± 0.3 | 0.06 ± 0.00 | |
| Stored ( | 5.0 ± 1.1 | 0.02 ± 0.00 | 5.4 ± 1.4 | 0.03 ± 0.00 | 5.5 ± 1.2 | 0.03 ± 0.00 | |
Lag phase or growth rate in samples with cryoprotectants is significantly different from the control samples within the same condition (P ˂ 0.05).
Lag phase or growth rate after processing and after storage is significantly different (B) from the fresh culture within the same treatment (P ˂ 0.05).
Figure 2Impact of cryoprotectants on membrane integrity of cryopreserved and lyophilized strict anaerobes. Percentage of intact cells in fresh (t 0), and cryopreserved (Cryo) and lyophilized (Lyo) B. thetaiotaomicron (A), E. hallii (B), B. obeum (C), R. intestinalis (D), A. caccae (E) and F. prausnitzii (F) after 3 months storage in control (no protectant) and treated cultures (t) (SI and GSI).
Impact of protectants and lyophilization on viable cell counts of fresh (t 0), processed (t 1) and stored (t 2) bacteria. Log viable cell counts ml−1 in the fresh culture, after lyophilization and storage for 3 months at 4°C, were assessed with the most probable number method (MPN). Recovery rate of viable cells (in %) was calculated relative to the average viable cell counts in the fresh control (vs. control t 0) and to fresh treatment culture (vs. t 0)
| Organism | Culture condition | Control | SI | ||
|---|---|---|---|---|---|
| MPN (ml−1) | Recovery vs. | MPN (ml−1) | Recover vs. control | ||
|
| Fresh ( | 9.3 ± 0.2 | 9.4 ± 0.2 | 135 | |
| Processed ( | 7.0 ± 0.5 | 1 | 8.0 ± 0.7 | 6/4 | |
| Stored ( | 5.4 ± 2.0 | 0.01 | 7.7 ± 0.4 | 3/2 | |
|
| Fresh ( | 7.9 ± 0.4 | 7.8 ± 0.4 | 79 | |
| Processed ( | 4.3 ± 1.2 | 0.02 | 6.6 ± 0.2 | 4/5 | |
| Stored ( | 2.3 ± 2.1 | 0.0003 | 5.5 ± 0.3 | 0.3/0.4 | |
|
| Fresh ( | 8.9 ± 0.4 | 8.9 ± 0.4 | 82 | |
| Processed ( | 6.3 ± 0.3 | 0.2 | 7.8 ± 0.4 | 7/8 | |
| Stored ( | 6.2 ± 0.2 | 0.2 | 7.6 ± 0.2 | 4/5 | |
|
| Fresh ( | 8.4 ± 0.2 | 8.4 ± 0.2 | 100 | |
| Processed ( | 4.9 ± 0.4 | 0.04 | 7.1 ± 0.1 | 6/6 | |
| Stored ( | 5.6 ± 0.2 | 0.2 | 6.8 ± 0.2 | 3/3 | |
|
| Fresh ( | 8.8 ± 0.3 | 8.9 ± 0.2 | 111 | |
| Processed ( | 6.4 ± 0.2 | 0.4 | 8.8 ± 0.3 | 87/71 | |
| Stored ( | 6.7 ± 0.5 | 1 | 8.6 ± 0.3 | 60/49 | |
|
| Fresh ( | 8.0 ± 0.2 | 8.2 ± 0.2 | 181 | |
| Processed ( | 6.1 ± 0.3 | 1 | 7.8 ± 0.4 | 58/32 | |
| Stored ( | 7.1 ± 0.4 | 14 | 7.8 ± 0.1 | 59/33 | |
Viable cell counts in samples with lyoprotectants are significantly different from the control samples within the same condition (P ˂ 0.05).
Viable cell counts after processing and after storage are significantly different from the viable cell counts of the fresh culture within the same treatment (P ˂ 0.05).
Impact of protectants and lyophilization on fitness of fresh (t 0) processed (t 1) and stored (t 1) bacteria. Lag phase (t lag) and maximum growth rate (µmax) were calculated from optical density growth curves based on Baranyi's equation
| Organism | Culture condition | Control | SI | ||
|---|---|---|---|---|---|
|
| µmax (OD*h−1) |
| µmax (OD*h−1) | ||
|
| Fresh ( | 0.7 ± 0.1 | 0.23 ± 0.01 | 0.7 ± 0.1 | 0.22 ± 0.01 |
| Processed ( | 7.5 ± 0.9 | 0.19 ± 0.01 | 3.4 ± 1.2 | 0.18 ± 0.01 | |
| Stored ( | 10.1 ± 3.5 | 0.16 ± 0.04 | 4.1 ± 1.9 | 0.14 ± 0.05 | |
|
| Fresh ( | 6.4 ± 2.2 | 0.14 ± 0.02 | 7.0 ± 2.1 | 0.14 ± 0.02 |
| Processed ( | 25.8 ± 0.3 | 0.25 ± 0.00 | 19.3 ± 2.1 | 0.21 ± 0.01 | |
| Stored ( | 25.5 ± 1.6 | 0.27 ± 0.00 | 21.5 ± 2.0 | 0.22 ± 0.03 | |
|
| Fresh ( | 1.6 ± 0.1 | 0.29 ± 0.02 | 1.6 ± 0.1 | 0.28 ± 0.01 |
| Processed ( | 9.8 ± 0.4 | 0.30 ± 0.01 | 5.6 ± 1.1 | 0.26 ± 0.01 | |
| Stored ( | 11.0 ± 0.5 | 0.25 ± 0.01 | 8.5 ± 0.4 | 0.21 ± 0.01 | |
|
| Fresh ( | 1.7 ± 0.7 | 0.35 ± 0.04 | 1.3 ± 0.2 | 0.30 ± 0.07 |
| Processed ( | 14.8 ± 0.2 | 0.27 ± 0.05 | 8.5 ± 0.7 | 0.37 ± 0.02 | |
| Stored ( | 13.0 ± 1.3 | 0.21 ± 0.12 | 8.6 ± 0.2 | 0.32 ± 0.04 | |
|
| Fresh ( | 1.5 ± 0.1 | 0.20 ± 0.03 | 1.3 ± 0.2 | 0.19 ± 0.03 |
| Processed ( | 8.9 ± 0.9 | 0.25 ± 0.02 | 2.7 ± 0.1 | 0.16 ± 0.01 | |
| Stored ( | 7.9 ± 0.3 | 0.21 ± 0.01 | 2.6 ± 0.4 | 0.15 ± 0.02 | |
|
| Fresh ( | 1.3 ± 0.1 | 0.05 ± 0.00 | 1.4 ± 0.1 | 0.05 ± 0.00 |
| Processed ( | 6.6 ± 0.4 | 0.04 ± 0.01 | 3.3 ± 0.4 | 0.06 ± 0.01 | |
| Stored ( | 5.7 ± 2.0 | 0.02 ± 0.01 | 2.8 ± 0.7 | 0.03 ± 0.01 | |
Lag phase or growth rate in samples with lyoprotectants is significantly different from the control samples within the same condition (P ˂ 0.05).
Lag phase or growth rate after processing and after storage is significantly different from the fresh culture within the same treatment (P ˂ 0.05).